FDA's drug screening program sidelined by IT issues

IT problems are being cited in the FDA delay of PREDICT, the Predictive Risk-Based Evaluation for Dynamic Import Compliance Targeting initiative. The program is intended to help customs officers prevent adulterated and counterfeit drugs from entering the U.S. Report